Cargando…

An analysis of ranibizumab treatment and visual outcomes in real-world settings: the UNCOVER study

PURPOSE: To describe intravitreal ranibizumab treatment frequency, clinical monitoring, and visual outcomes (including mean central retinal thickness [CRT] and visual acuity [VA] changes from baseline) in neovascular age-related macular degeneration (nAMD) in real-world settings across three ranibiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Eldem, Bora, Lai, Timothy Y. Y., Ngah, Nor Fariza, Vote, Brendan, Yu, Hyeong Gon, Fabre, Alban, Backer, Arthur, Clunas, Nathan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911274/
https://www.ncbi.nlm.nih.gov/pubmed/29502232
http://dx.doi.org/10.1007/s00417-017-3890-8